Skip to main content
Loading

Poster Presentation: Designing Smart Toxicology Packages for Oligo and Peptide Therapeutics

26 Sep 2025
Oligonucleotide CMC & Process Development
Examine regulatory expectations and case studies on toxicity pathways specific to oligonucleotides and peptides, including immune activation, off-target hybridization, and renal/hepatic effects.